This site is intended for healthcare professionals only
LoginRegister
NPPA Fixes Ceiling Price Of Disposable pen containing insulin glargineNPPA Fixes Ceiling Price Of Disposable pen containing insulin glargine
USFDA nod to JnJ Tremfya for Crohns diseaseJ&J Gets CDSCO Panel Nod To Conduct Phase IV CT of Ustekinumab
Present More Data On Almitrine, Ifenprodil: CDSCO Panel Tells CDRI-CSIRPresent More Data On Almitrine, Ifenprodil: CDSCO Panel Tells CDRI-CSIR
Bayer Chairman Norbert Winkeljohann wins backing from major shareholder advisory firmsBayer Chairman Norbert Winkeljohann wins backing from major shareholder advisory firms
Novo Nordisk Projects Oral Weight-Loss Pills to Take One-Third of GLP-1 Market by 2030Novo Nordisk raises full-year forecast on GLP-1 drug sales
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer signs strategic cooperation pact with Sinopharm
Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, EuropeRevise Phase III CT protocol: CDSCO Panel Tells Dr Reddy's over Tegoprazan
USFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoeaRevise Phase IV CT Protocol: CDSCO panel tells Zydus Lifesciences on Typhoid Vi Conjugate Vaccine...
Abbott to Conduct BE Study for Carbimazole 15 mg, Trial Waiver Granted In IndiaCDSCO Panel Grants Abbott's Protocol Amendment Proposal For Ursodeoxycholic Acid
Novavax cut USD 50 million in costs, plans to slash more: CEONovavax cut USD 50 million in costs, plans to slash more: CEO
CDSCO Panel Directs Abbott to Incorporate New Safety, Follow-up Measures in Clarithromycin StudyUSFDA clears reader for Abbott FreeStyle Libre 3 system
USFDA pauses initiation of new patients on multiple sclerosis evobrutinib drug: MerckUSFDA pauses initiation of new patients on multiple sclerosis evobrutinib drug: Merck
X